Search results
Results from the WOW.Com Content Network
3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid) and its salts, optical and geometric isomers, and salts of isomers MDMA and other "ecstasy"-type substances Alpha-phenylacetoacetamide (APAA) and its optical isomers amphetamine, methamphetamine: Methyl alpha-phenylacetoacetate (MAPA; methyl 3-oxo-2-phenylbutanoate) and its optical isomers
2014, CCRPP Press Office Zagreb, Croatia—retrieved 4. January 2014; Office of Narcotics Control & You: The Inside Dope (General Membership Manual of the NCOTCL, First Edition, 21. May 1990; Proceedings for the 8. March 2002 meeting of NCOTCL North American Section; 2014 CCRPP Press Office Zagreb, Croatia—retrieved 4. January 2014
Office of Diversion Control - Drug Enforcement Administration. U.S. Department of Justice. Archived from the original on 2018-12-21 "Drug Control:Implementation of the Chemical Diversion and Trafficking Act of 1988" (PDF). U.S. GAO ~ GGD-91-56BR. U.S. Government Accountability Office. April 3, 1991. OCLC 25035561.
Prior to October 1, 1985, DEA registration numbers for physicians, dentists, veterinarians, and other practitioners started with the letter A. New registration numbers issued to practitioners after that date begin with the letter B, F, or G. [3] [4] The rest of the format was the same as the new style.
Cardinal, alongside McKesson Corporation and AmerisourceBergen, spent $13 million lobbying Congress to pass Congressman Tom Marino's "Ensuring Patient Access and Effective Drug Enforcement Act". [9] The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President Barack Obama in ...
The Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91–513, 84 Stat. 1236, enacted October 27, 1970, is a United States federal law that, with subsequent modifications, requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs. [1]
Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. [1] The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. “doctor shopping”) and reducing diversion of controlled substances.
The Drug Enforcement Administration was established on July 1, 1973, [4] by Reorganization Plan No. 2 of 1973, signed by President Richard Nixon on July 28. [5] It proposed the creation of a single federal agency to enforce the federal drug laws as well as consolidate and coordinate the government's drug control activities.